This is the year you finally find a liquid lipstick that lasts, stop letting dishes pile up in the sink, and upgrade your WFH ...
Pfizer Inc. today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERBITUX®) and mFOLFOX6 (fluorouracil, ...